a:5:{s:8:"template";s:9184:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300%2C300i%2C400%2C400i%2C600%2C600i%2C800%2C800i&amp;subset=latin%2Clatin-ext" id="bulk-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}p.has-drop-cap:not(:focus)::first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}p.has-drop-cap:not(:focus)::after{content:"";display:table;clear:both;padding-top:14px} @font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:300;src:local('Roboto Condensed Light Italic'),local('RobotoCondensed-LightItalic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVg2ZhZI2eCN5jzbjEETS9weq8-19eDpCEoY9Nc.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:400;src:local('Roboto Condensed Italic'),local('RobotoCondensed-Italic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVj2ZhZI2eCN5jzbjEETS9weq8-19eLAQM4.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:300;src:local('Roboto Condensed Light'),local('RobotoCondensed-Light'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVi2ZhZI2eCN5jzbjEETS9weq8-33mZGCoYag.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:400;src:local('Roboto Condensed'),local('RobotoCondensed-Regular'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVl2ZhZI2eCN5jzbjEETS9weq8-19y7CA.ttf) format('truetype')} /*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}.text-center{text-align:center}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-brand{float:left;padding:15px 15px;font-size:18px;line-height:20px;height:50px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}@media (min-width:768px){.navbar-right{float:right!important;margin-right:-15px}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{content:" ";display:table}.container-fluid:after,.container:after,.nav:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}body,html{overflow-x:hidden}body{font-family:'Roboto Condensed',"Helvetica Neue",helvetica,arial,sans-serif;padding:0;color:#404040;font-weight:400;line-height:1.8;font-size:16px;word-wrap:break-word;overflow-x:hidden}a,a:active,a:focus,a:hover{text-decoration:none;color:#0090ff}ul{padding-left:20px}a:active{border-bottom:none}.page-area{padding-top:70px}@media (min-width:768px){.navbar-nav>li>a{padding-top:25px;padding-bottom:25px;transition:all .5s ease-in-out;-moz-transition:all .5s ease-in-out;-webkit-transition:all .5s ease-in-out;-o-transition:all .5s ease-in-out}#site-navigation .container{padding-left:0;padding-right:0}}@media (max-width:767px){.navbar-nav a:focus,.navbar-nav a:hover{color:#fff!important;background-color:#000!important}.menu-container{width:70%;position:absolute;left:0;height:100vh;transform:translate3d(-100%,0,0);overflow-y:auto;overflow-x:auto;background-color:#fff;top:100%}.navbar-brand{padding-right:55px!important}.page-area{left:0;transform:translate3d(0,0,0);transition:transform .5s ease}.navbar-nav{padding:0;margin:0}.navbar-nav a{font-size:14px;padding:12px 10px!important;margin:0!important;line-height:16px!important;float:left!important;margin:0!important;width:100%;text-transform:none!important;word-wrap:break-word;white-space:normal!important}.navbar-nav li{padding:0!important;margin:0!important}}#site-navigation{min-height:70px}.navbar-nav>li>a{border-bottom:0;text-transform:uppercase}.site-title{margin:0;padding:0;font-size:22px;line-height:28px}p.site-description{font-size:13px;line-height:18px;margin:0;-webkit-transition:all .5s ease;transition:all .5s ease}.site-branding-logo{float:left}.site-branding-logo a{border:none;z-index:9999;position:relative}.navbar-brand{padding:10px 15px;height:auto;z-index:99999;position:relative;z-index:1}.navbar{margin-bottom:0}.main-menu{position:relative}.navbar-fixed-top{position:absolute}#site-navigation{background-color:#fff;-webkit-box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);border:none}#site-navigation,nav a{-webkit-transition:all .3s ease;transition:all .3s ease;color:#000}.footer-credits{border-top:1px solid #ccc;padding:15px;clear:both;margin-top:20px;background-color:#fff}</style>
 </head>
<body class="wp-custom-logo" id="blog">
<div class="main-menu">
<nav class="navbar navbar-default navbar-fixed-top" id="site-navigation">
<div class="container">
<div class="navbar-header">
<div class="site-header">
<div class="site-branding-logo">
<a class="custom-logo-link" href="#" itemprop="url" rel="home"></a> </div>
<div class="site-branding-text navbar-brand">
<p class="site-title"><a href="#" rel="home">{{ keyword }}</a></p>
<p class="site-description">
{{ keyword }}</p>
</div>
</div>
</div>
<div class="menu-container"><ul class="nav navbar-nav navbar-right" id="menu-menu-1"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-72 dropdown" id="menu-item-72"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="Projects">Projects</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-73 dropdown" id="menu-item-73"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="About">About</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-74" id="menu-item-74"><a href="#" title="Contacts">Contacts</a></li>
</ul></div> </div>
</nav>
</div>
<div class="page-area">	
{{ text }}
<br>
<br>
{{ links }}
</div>
<footer class="footer-credits container-fluid row" id="colophon">
<div class="container">
<p class="footer-credits-text text-center">{{ keyword }} 2020</p>
</div>
</footer>
</body>
</html>";s:4:"text";s:8075:"Adjusted net earnings(1) of $699 million decreased 2.1% in the quarter. Kevin, I just wanted to ask kind of a big-picture question to you, and then I do have a follow-up. So, don't read anything more into that other than it's a management structure change to give more businesses to Andy and Spence to manage directly, and it's a recognition of just how well they've performed over time. As Kevin referenced, I believe, on this call, and I'm sure we'll talk about in academy, we do have some new hip software coming to help facilitate that procedure. I would say it's improved, and that's really the trajectory on spine, is there's still improvement to go, of course, because we still have legacy spine products in manufacturing that we're optimizing. Got it. And then, just with respect to Mako in Japan, you've got the full indications across the portfolio. Where do you see the biggest opportunities, especially as you move into the next 12 months? We believe that these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Hi, guys. We will now begin the question and answer session. Maybe you can just help provide us with some color just on that opportunity. All other divisions achieved mid-single digit gains despite challenging comparisons. ... Q1 2020 Stryker Corp Earnings Call 04/30/2020 04:30 PM (EDT) SYK. Yeah. Hey, Kevin. Compared to the prior-year quarter, gross margin expansion was favorably impacted by acquisitions and foreign exchange, which were partially offset by price and business mix. Neurotechnology and Spine net sales of $0.7 billion increased 0.7% in the quarter and 1.5% in constant currency. Image source: The … Can you provide an update on the deformity opportunity that you see ahead, and how that portfolio maybe provides an opportunity for pull-through of more traditional degenerative products for you guys? So just sort of curious, what drove those very significant Mako placements? We are so underrepresented there relative to our overall portfolio and market shares around the world. In the past years, we have strengthened our international businesses and have taken key steps to strengthen category leadership across our portfolio. In general, Japan, it will grow. There is one additional selling day in 2020, compared to 2019. We also expect continued unfavorable price reductions of 1% to 1.5%, which is fairly consistent with the pricing environment experienced in 2019. Does it continue at that kind of level? And then I had a quick follow-up. Yeah. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. One, with Cardan, which came with the Mobius acquisition, as well as Mako. But for the moment, it doesn't appear to be significant. We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (GAAP) with certain non-GAAP financial measures, including: percentage sales growth; percentage sales growth in constant currency;  percentage organic sales growth; adjusted gross profit; adjusted selling, general and administrative expenses; adjusted research, development and engineering expenses; adjusted operating income; adjusted other income (expense), net; adjusted effective income tax rate; adjusted net earnings; and adjusted net earnings per diluted share (Diluted EPS). So, one housekeeping question here on the guidance, you know, below the line. The registration process and some of the software has been a little bit challenging from a change management standpoint. We're expecting a big year in 2020. This reflects increased adjusted earnings, which are somewhat offset by increases in working capital and increased acquisition integration and restructuring spending. I think we said that at the beginning of the year. Yeah. And now, I will provide 2020 guidance on a stand-alone basis and further guidance, including right medical. You know, going back to, I guess, one of the original questions. Our orthopedics performance continues to reflect meaningful share gains fueled by Mako and our 3D-printed implants. I will now turn the call over to Mr. Kevin Lobo, chairman and chief executive officer. Sure, sure. Management Presents at the Bank of America Merrill Lynch 2019 Health Care Con... CEO Kevin Lobo on Q1 2019 Results - Earnings Call Transcript, CEO Kevin Lobo on Q4 2018 Results - Earnings Call Transcript, Q4 2018 Earnings Conference Call Transcript, Management Presents at Evercore ISI HealthCONx Conference (Transcript), Q3 2018 Earnings Conference Call Transcript, Q3 2018 Results - Earnings Call Transcript, CEO Kevin Lobo on Q2 2018 Results - Earnings Call Transcript, Q1 2018 Results - Earnings Call Transcript, CEO Kevin Lobo on Q4 2017 Results - Earnings Call Transcript, Q3 2017 Results - Earnings Call Transcript, Q2 2017 Results - Earnings Call Transcript, Q1 2017 Results - Earnings Call Transcript, CEO Kevin Lobo on Q4 2016 Results - Earnings Call Transcript, Q3 2016 Results - Earnings Call Transcript, CEO Kevin Lobo on Q1 2016 Results - Earnings Call Transcript, Kevin Lobo on Q4 2015 Results - Earnings Call Transcript, Kevin A. Lobo on Q3 2015 Results - Earnings Call Transcript, CEO Kevin Lobo on Q2 2015 Results - Earnings Call Transcript, CEO Kevin Lobo Discusses Q1 2015 Results - Earnings Call Transcript, CEO Kevin Lobo on Q4 2014 Results - Earnings Call Transcript, CEO Kevin Lobo on Q3 2014 Results - Earnings Call Transcript, CEO Kevin Lobo on Q2 2014 Results - Earnings Call Transcript, Stryker's CEO Discusses Q1 2014 Results - Earnings Call Transcript, Stryker Management Discusses Q4 2013 Results - Earnings Call Transcript, Stryker Management Discusses Q3 2013 Results - Earnings Call Transcript, Stryker Corporation Hosts Analyst Meeting (Transcript), CEO Discusses Q2 2013 Results - Earnings Call Transcript. Such factors include, but are not limited to: the impact on our operations and financial results of the COVID-19 pandemic and any related policies and actions by governments or other third parties; the failure to satisfy any of the closing conditions to the acquisition of Wright Medical Group N.V. ("Wright"), including the receipt of any required regulatory clearances (and the risk that such clearances may result in the imposition of conditions that could adversely affect the expected benefits of the transaction); timing of the closing of the acquisition of Wright; unexpected liabilities, costs, charges or expenses in connection with the acquisition of Wright; the effects of the proposed Wright transaction (or the announcement thereof) on the parties' relationships with employees, customers, other business partners or governmental entities; weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products, including Wright products; potential supply disruptions; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; the ultimate total cost with respect to recall-related matters; the impact of investigative and legal proceedings and compliance risks; resolution of tax audits; the impact of the federal legislation to reform the United States healthcare system; costs to comply with medical device regulations; changes in financial markets; changes in the competitive environment; our ability to integrate and realize the anticipated benefits of acquisitions in full or at all or within the expected timeframes, including the acquisition of Wright; and our ability to realize anticipated cost savings. ";s:7:"keyword";s:40:"stryker earnings call transcript q1 2020";s:5:"links";s:1595:"<a href="http://newdestinychurchpc.com/blog/article.php?tag=crocs-literide-uae-6bb478">Crocs Literide Uae</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=hang-seng-forecast-2020-6bb478">Hang Seng Forecast 2020</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=Nikolaj-Ehlers-wife-6bb478">Nikolaj Ehlers Wife</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=dow-jones-high-2020-6bb478">Dow Jones High 2020</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=mamma-mia-2-songs-in-order-6bb478">Mamma Mia 2 Songs In Order</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=tom-petty-songs-6bb478">Tom Petty Songs</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=i%27m-looking-through-you-chords-6bb478">I'm Looking Through You Chords</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=jeff-petry-wife-6bb478">Jeff Petry Wife</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=switch-eshop-superhot-6bb478">Switch Eshop Superhot</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=the-guards%3A-inside-the-k-episode-3-6bb478">The Guards: Inside The K Episode 3</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=what-are-non-deferrable-business-expenses-6bb478">What Are Non-deferrable Business Expenses</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=remo%2B-%27s-doorbell-login-6bb478">Remo+ 's Doorbell Login</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=evander-kane-hat-trick-6bb478">Evander Kane Hat Trick</a>,
";s:7:"expired";i:-1;}